StreetAlpha.app
Home › Stocks › CSTL

Castle Biosciences Inc (CSTL)

$32.98
▲ +0.70%
LAST CLOSE · NOV 17

Castle Biosciences sells molecular diagnostic tests that help clinicians diagnose and treat skin cancers and certain other conditions. It last closed at $32.98 on Nov 17, up 0.70% on the day. The average 12-month price target from 3 analysts is $44.33 (+34.4% from the last close), with a high of $52.00 and a low of $40.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is CSTL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$377.1M
+9.8% vs a year ago
Net income
−$23.0M
−6.1% margin
EPS (diluted)
−$0.76
Free cash flow
$4.0M
1.1% margin
Valuation
Market cap
$1.0B
30.8M shares
P/E
–
No P/E while losing money
Price to sales
2.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$78.0M
At Sep 30
Debt
$10.1M
At Sep 30
Shareholder equity
$478.4M
Shares outstanding
30.8M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $94.1M$94.1MFY2021FY2022: $137.0M$137.0MFY2022FY2023: $219.8M$219.8MFY2023FY2024: $332.1M$332.1MFY2024FY2025: $344.2M$344.2MFY2025

From CSTL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on CSTL in the past 90 days
Average 12-month target
$44.33
▲ 34.4% upside

Based on 3 analysts who set a price target on CSTL in the past 90 days. The average target is $44.33, with a high of $52.00 and a low of $40.00, compared with the last close of $32.98.

Low $40.00Avg $44.33High $52.00
Blue marker: last close $32.98
Highest target$52.00
Average target$44.33
Lowest target$40.00
Latest rating changes
BTIGTarget raised
Nov 10Buy$44 → $52
BairdMaintained
Nov 9Buy$41
KeybancMaintained
Nov 6Buy$40
BTIGMaintained
Aug 3Buy$44
Roth CapitalInitiated
Jun 25Buy$40
DateFirmActionRatingPrice target
Nov 10BTIGTarget raisedBuy$44 → $52
Nov 9BairdMaintainedBuy$41
Nov 6KeybancMaintainedBuy$40
Aug 3BTIGMaintainedBuy$44
Jun 25Roth CapitalInitiatedBuy$40
Loading…

Technical Analysis

CSTL · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 5% below its 20 day and 4% below its 50 day average. It is 15% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 45). The nearest support is the swing low (Aug 31) at $32.36, and the nearest resistance the swing high (Aug 10) at $33.06.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 5.5%/day
Key levels
$44.2852 week high+34.3%
$34.5120 day average+4.6%
$34.3550 day average+4.2%
$33.88Pivot R1+2.7%
$33.19Pivot+0.6%
$33.06Swing high (Aug 10)+0.2%
$32.98Last close
$32.36Swing low (Aug 31)−1.9%
$32.30Pivot S1−2.1%
$31.42100 day average−4.7%
$28.12200 day average−14.7%
$17.7252 week low−46.3%
Indicators
RSI (14)45.06Middle of its rangeNeutral
MACD-0.19Below its signal lineBearish
Stochastic19.7Near the bottom of its rangeOversold
ADX (14)13.8No clear trend
Williams %R-83.1Oversold below −80, overbought above −20Oversold
CCI (20)-78.9Oversold below −100, overbought above 100Neutral
Rate of change−6.2%Change over 10 sessionsBearish
ATR (14)$1.83Typical daily range, 5.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for CSTL

What happened before

See how CSTL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CSTL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CSTL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in CSTL in the last 90 days.

Loading…

See today’s whale options flow across the market →

CSTL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲121 buying vs 83 selling
  • ▲Held by funds +3.3 pts
  • ▲Funds holding +26
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding202176+14.8%
In funds' top 1010–
Held by funds92.0%88.7%+3.3 pts
New / increased50 / 7121 / 77+23.5%
Reduced / sold out58 / 2554 / 30−1.2%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CSTL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CSTL is in one of them and how their past CSTL trades turned out.

CSTL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CSTL in an article yet. Here's the latest on the wider market.

CSTL Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 17
Who traded CSTL · since 2020
Latest 3 filings
Josh GottheimerSell (partial)
$1K – $15KTraded Mar 15, 2022Filed Apr 17, 2022
$1K – $15KTraded Dec 23, 2020Filed Jan 11, 2021
$1K – $15KTraded Dec 21, 2020Filed Jan 7, 2021
PersonTypeAmountTradedFiledDelay
Josh GottheimerD · NJSell (partial)$1K – $15KMar 15, 2022Apr 17, 202233 d
Gilbert CisnerosD · CABuy$1K – $15KDec 23, 2020Jan 11, 202119 d
Josh GottheimerD · NJBuy$1K – $15KDec 21, 2020Jan 7, 202117 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Castle Biosciences

Castle Biosciences is a molecular diagnostics company based in Friendswood, Texas. It offers laboratory tests that help clinicians diagnose and manage treatment for skin cancers, Barrett's esophagus, uveal melanoma and atopic dermatitis. Its tests analyze patient samples to help estimate risk, guide treatment decisions and support diagnosis, and they are used by clinicians caring for these patients.

Headquarters
Friendswood, TX